GIBSON DANIEL GLENN (Chief Technology Officer) sold 1.2% of their position (1.19K shares) of TELESIS BIO INC. on the open market
Open‑market sale worth $3.4K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 5/8/2023ACC: 0001209191-23-028114
Officer· Chief Technology Officer
Since Jun 2021
-1.19K
Net shares
Net seller
$3.4K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
1.19K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−1.19K
Price / share
$2.83
Trade value
$3.36K
% of position
1.2%
5/4/2023
103.27K→102.08K
Total
Net shares
−1.19K
Net value
-$3.36K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/4/2023 | S · Sale | −1.19K | $2.83 | $3.36K | 1.2% | 103.27K | 102.08K |
| Total | −1.19K | -$3.36K | ||||||
Derivative Transactions0
No derivative transactions reported